The DOI matches its Crossref record.
Molecular Mechanism of Cyclodextrin Mediated Cholesterol Extraction
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“APOE4 astrocytes also exhibited reduced cholesterol efflux in the presence of 2% HDL and the cholesterol chelator methyl-β-cyclodextrin (MBCD), a measure of the total available cholesterol in the plasma membrane using fluorescently-labeled cholesterol (Figure 6L)(Lopez et al., 2011; Zhang et al., 2011).”
From Cholesterol and matrisome pathways dysregulated in astrocytes and microglia (2022) · cites this paper as Lopez et al., 2011
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 47
- ED Valle, 2004, Cyclodextrins and their uses: a review., Process Biochem, 39, 1033, 10.1016/S0032-9592(03)00258-9 · DOI · Paper page
- VJ Stella, 2008, Cyclodextrins., Toxicol Pathol, 36, 30, 10.1177/0192623307310945 · DOI
- A Vyas, 2008, Cyclodextrin based novel drug delivery systems., J Inclusion Phenom Macrocyclic Chem, 62, 23, 10.1007/s10847-008-9456-y · DOI · Paper page
- ME Davis, 2004, Cyclodextrin-based pharmaceutics: past, present and future., Nat Rev Drug Discov, 3, 1023, 10.1038/nrd1576 · DOI
- Y Yu, 2008, Solubility of beta-cyclodextrin in different mixed solvents., Pet Sci, 5, 263, 10.1007/s12182-008-0044-y · DOI
- T Ogoshi, 2008, Chemical sensors based on cyclodextrin derivatives., Sensors, 8, 4961, 10.3390/s8084961 · DOI
- F van de Manakker, 2009, Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications., Biomacromolecules, 10, 3157, 10.1021/bm901065f · DOI
- A Harada, 2009, Cyclodextrin-based supramolecular polymers., Chem Soc Rev, 38, 875, 10.1039/b705458k · DOI
- E Bilensoy, 2009, Recent advances and future directions in amphiphilic cyclodextrin nanoparticles., Expert Opin Drug Deliv, 6, 1161, 10.1517/17425240903222218 · DOI
- M Messner, 2010, Self-assembled cyclodextrin aggregates and nanoparticles., Int J Pharm, 387, 199, 10.1016/j.ijpharm.2009.11.035 · DOI
- R Zidovetzki, 2007, Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies., Biochim Biophys Acta, 1768, 1311, 10.1016/j.bbamem.2007.03.026 · DOI
- VM Atger, 1997, Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells., J Clin Invest, 99, 773, 10.1172/JCI119223 · DOI
- R Leventis, 2001, Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol., Biophys J, 81, 2257, 10.1016/S0006-3495(01)75873-0 · DOI · Paper page
- J Mascetti, 2008, Organization of beta-cyclodextrin under pure cholesterol, dmpc, or dmpg and mixed cholesterol/phospholipid monolayers., Langmuir, 24, 9616, 10.1021/la8004294 · DOI
- H Ohvo, 1996, Cyclodextrin-mediated removal of sterols from monolayers: effects of sterol structure and phospholipids on desorption rate., Biochemistry, 35, 8018, 10.1021/bi9528816 · DOI
- PG Yancey, 1996, Cellular cholesterol efflux mediated by cyclodextrins demonstration of kinetic pools and mechanism of efflux., J Biol Chem, 271, 16026, 10.1074/jbc.271.27.16026 · DOI
- Y Ohtani, 1989, Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes., Eur J Biochem, 186, 17, 10.1111/j.1432-1033.1989.tb15171.x · DOI
- R Ravichandran, 1998, Inclusion of ring a of cholesterol inside the beta-cyclodextrin cavity: Evidence from oxidation reactions and structural studies., J Incl Phenom Macrocyclic Chem, 30, 253, 10.1023/A:1007912809965 · DOI
- C Betzel, 1984, Topography of cyclodextrin inclusion complexes, part 20 circular and ip-op hydrogen bonding in beta-cyclodextrin undecahydrate: a neutron diffraction study., J Am Chem Soc, 106, 7545, 10.1021/ja00336a039 · DOI
- MP Besenicar, 2008, Kinetics of cholesterol extraction from lipid membranes by methyl-beta-cyclodextrin-a surface plasmon resonance approach., Biochim Biophys Acta, 1778, 175, 10.1016/j.bbamem.2007.09.022 · DOI
- H Ohvo-Rekilä, 2000, Cyclodextrin-catalyzed extraction of unresent sterols from monolayer membranes and small unilamellar vesicles., Chem Phys Lipids, 105, 167, 10.1016/S0009-3084(00)00122-5 · DOI
- D Castagne, 2009, Study of the cholesterol extraction capacity of beta-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models., J Incl Phenom Macrocyclic Chem, 63, 225, 10.1007/s10847-008-9510-9 · DOI
- YH Choi, 2001, Molecular modeling studies of the beta-cyclodextrin in monomer and dimer form as hosts for the complexation of cholesterol., J Incl Phenom Macrocyclic Chem, 39, 71, 10.1023/A:1008196029391 · DOI
- Y Yu, 2006, Molecular dynamics study of the inclusion of cholesterol into cyclodextrins., J Phys Chem B, 110, 6372, 10.1021/jp056751a · DOI
- J Hernández-Pascacio, 2007, Cyclodextrinbased self-assembled nanotubes at the water/air interface., J Phys Chem B, 111, 12625, 10.1021/jp076576t · DOI
- P Weinzinger, 2007, Molecular dynamics simulations and quantum chemical calculations on beta-cyclodextrin spironolactone complex., J Incl Phenom Macrocyclic Chem, 57, 29, 10.1007/s10847-006-9165-3 · DOI
- A Piñeiro, 2007, On the characterization of host-guest complexes: surface tension, calorimetry, and molecular dynamics of cyclodextrins with a non-ionic surfactant., J Phys Chem B, 111, 4383, 10.1021/jp0688815 · DOI
- A Tsamaloukas, 2005, Interactions of cholesterol with lipid membranes and cyclodextrin characterized by calorimetry., Biophys J, 89, 1109, 10.1529/biophysj.105.061846 · DOI
- RO Williams, 1998, Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin., Eur J Pharm Biopharm, 46, 355, 10.1016/S0939-6411(98)00033-2 · DOI
- J Hernández-Pascacio, 2008, A small molecular size system giving unexpected surface effects: alpha-cyclodextrin+sodium dodecyl sulfate in water., J Colloid Interface Sci, 328, 391, 10.1016/j.jcis.2008.09.002 · DOI
- Y He, 2008, Cyclodextrin-based aggregates and characterization by microscopy., Micron, 39, 495, 10.1016/j.micron.2007.06.017 · DOI
- P Bonnet, 2002, Structure and thermodynamics of alpha-, beta-, and gamma-cyclodextrin dimers. molecular dynamics studies of the solvent effect and free binding energies., J Org Chem, 67, 8602, 10.1021/jo026166v · DOI
- HW Frijlink, 1991, The effect of parenterally administered cyclodextrins on cholesterol levels in the rat., Pharm Res, 8, 9, 10.1023/A:1015861719134 · DOI
- R Breslow, 1996, Cholesterol recognition and binding by cyclodextrin dimers., J Am Chem Soc, 118, 8495, 10.1021/ja961567b · DOI
- J Nishijo, 2003, Interactions of cholesterol with cyclodextrins in aqueous solution., Chem Pharm Bull (Tokyo), 51, 1253, 10.1248/cpb.51.1253 · DOI
- WF Bennett, 2009, Molecular view of cholesterol ip-op and chemical potential in different membrane environments., J Am Chem Soc, 131, 12714, 10.1021/ja903529f · DOI
- PO Montiel, 2000, Soluble carbohydrates (trehalose in particular) and cryoprotection in polar biota., Cryo Letters, 21, 83
- B Hess, 2008, Gromacs 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation., J Chem Theory Comput, 4, 435, 10.1021/ct700301q · DOI
- RD Lins, 2005, A new gromos force field for hexopyranose-based carbohydrates., J Comput Chem, 26, 1400, 10.1002/jcc.20275 · DOI
- M Höltje, 2001, Molecular dynamics simulations of stratum corneum lipid models: fatty acids and cholesterol., Biochim Biophys Acta, 1511, 156, 10.1016/S0005-2736(01)00270-X · DOI
- B Hess, 1997, Lincs: A linear constraint solver for molecular simulations., J Comput Chem, 18, 1463, 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H · DOI
- WF van Gunsteren, 1990, Computer simulation of molecular dynamics: Methodology, applications, and perspectives in chemistry., Angew Chem Int Ed, 29, 992, 10.1002/anie.199009921 · DOI
- I Tironi, 1995, A generalized reaction field method for molecular dynamics simulations., J Chem Phys, 102, 5451, 10.1063/1.469273 · DOI
- HJC Berendsen, 1984, Molecular dynamics with coupling to an external bath., J Chem Phys, 81, 3684, 10.1063/1.448118 · DOI
- G Torrie, 1977, Nonphysical sampling distributions in monte carlo free-energy estimation: Umbrella sampling., J Comput Phys, 23, 187, 10.1016/0021-9991(77)90121-8 · DOI · Paper page
- S Kumar, 1992, The weighted histogram analysis method for free-energy calculations on biomolecules. i. the method., J Comput Chem, 13, 1011, 10.1002/jcc.540130812 · DOI · Paper page
- D Shoup, 1982, Role of diffusion in ligand binding to macromolecules and cell-bound receptors., Biophys J, 40, 33, 10.1016/S0006-3495(82)84455-X · DOI
Cited by
Sorted by citations
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363
Wang, L. L., Liu, Y., Chung, J. J., Wang, T., Gaffey, A. C., Lu, M., Cavanaugh, C. A., Zhou, S., Kanade, R., Atluri, P., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0157-y · Cited by 239
Yalcin, A., Soddu, E., Turunc Bayrakdar, E., Uyanikgil, Y., Kanit, L., Armagan, G., Rassu, G., Gavini, E., & Giunchedi, P. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.05.017 · Cited by 37
Metadata
- Authors
- López, C. A., de Vries, A. H., & Marrink, S. J.
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-24
- Volume
- 7
- Issue
- 3
- Pages
- e1002020
- ISSN
- 1553-7358
- PMC
- PMC3063748
- Cited by
- 198
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review